ATAD2 promotes glycolysis and tumor progression in clear cell renal cell carcinoma by regulating the transcriptional activity of c-Myc

Clear cell renal cell carcinoma (ccRCC) is a common malignant tumor of the urogenital tract. Given that ccRCC is often resistant to radiotherapy and traditional chemotherapy, the clinical treatment of patients with ccRCC remains a challenge. The present study found that ATAD2 was significantly upreg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zonglong, Ge, Liyuan, Song, Yimeng, Deng, Shaohui, Duan, Peichen, Du, Tan, Wu, Yaqian, Zhang, Zhanyi, Hou, Xiaofei, Ma, Lulin, Zhang, Shudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219916/
https://www.ncbi.nlm.nih.gov/pubmed/37233956
http://dx.doi.org/10.1007/s12672-023-00696-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219916/
https://www.ncbi.nlm.nih.gov/pubmed/37233956
http://dx.doi.org/10.1007/s12672-023-00696-1

Ejemplares similares